We reasoned that Sec61 blockade may represent a novel therapeutic approach of interest in MM, by inducing proteotoxic stress responses while preventing the expression of membrane receptors that are key to MM cell division and dissemination. Here, SEC61A1 is linked to Miyoshi myopathy.